| Dr Stuart Liederson, MD | |
|
3121 Route 9w, Suite 104, New Windsor, NY 12553-6722 | |
| (845) 562-2272 | |
| (845) 562-1973 |
| Full Name | Dr Stuart Liederson |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 3121 Route 9w, New Windsor, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083680649 | NPI | - | NPPES |
| 1083680649 | Other | NY | QUEENS |
| 1730276395 | Other | NY | EMPIRE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 209961 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stuart Liederson, MD 3121 Route 9w, Suite 104, New Windsor, NY 12553-6722 Ph: (845) 562-2272 | Dr Stuart Liederson, MD 3121 Route 9w, Suite 104, New Windsor, NY 12553-6722 Ph: (845) 562-2272 |
News Archive
Onyx Pharmaceuticals, Inc. today announced updated safety data from the pivotal Phase 2b 003-A1 study, known as the 003 trial, demonstrating that carfilzomib is well-tolerated in heavily pre-treated relapsed and refractory multiple myeloma patients.
A University of Alabama at Birmingham study released today reports that ovarian cancer screenings do not reduce a woman's risk of death from the disease and the invasive medical procedures may create associated health problems.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced financial results for the three-month period and fiscal year ended June 30, 2010.
The American Academy of Orthopaedic Surgeons (AAOS) has joined forces with the Orthopaedic Trauma Association (OTA) on a public service announcement (PSA) urging drivers to NEVER text while driving. Simply put, texting is a deadly distraction that can cause accidents, severe orthopaedic injuries or even death. Orthopaedic surgeons not only treat, but want to prevent accidental traumas.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
› Verified 1 days ago
Frederick C Beckett Iii, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 484 Temple Hill Rd, Suite 104, New Windsor, NY 12553 Phone: 845-565-3700 | |
Dr. Joseph George, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 575 Hudson Valley Ave, Ste 200, New Windsor, NY 12553 Phone: 845-561-2773 Fax: 914-593-7881 | |
Dr. Perla Joyce Andin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 905 Little Britain Rd, New Windsor, NY 12553 Phone: 845-564-7066 Fax: 845-549-1044 | |
Anne R. Mullin, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3068 Route 9w Ste 200, New Windsor, NY 12553 Phone: 845-534-9590 Fax: 845-534-9685 | |
Mahavir Singh, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3074 9 W South, New Windsor, NY 12553 Phone: 845-561-8902 Fax: 845-561-8910 | |
Arif M Muslim, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 955 Little Britain Rd, New Windsor, NY 12553 Phone: 845-562-0740 |